Volume 12, Issue 4 (June 2018)
Qom Univ Med Sci J 2018, 12(4): 10-15 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Sarkeshikian S S, Ghadir M R, Jahangiri M, Molaei M, Alemi F, Biderafsh A et al . The Effect of Antiviral Therapy with Tenofovir on Liver Fibrosis and Liver Function in Patients with Chronic Hepatitis B. Qom Univ Med Sci J 2018; 12 (4) :10-15
URL: http://journal.muq.ac.ir/article-1-2025-en.html
URL: http://journal.muq.ac.ir/article-1-2025-en.html
Seyyed Saeed Sarkeshikian1 
, Mohammad Reza Ghadir1 , Mahdi Jahangiri1 , Mansureh Molaei1 , Faezeh Alemi1 , Azam Biderafsh2 , Ahmad Hormati * 3
, Mohammad Reza Ghadir1 , Mahdi Jahangiri1 , Mansureh Molaei1 , Faezeh Alemi1 , Azam Biderafsh2 , Ahmad Hormati * 3
1- Gastroenterology & Hepatology Disease Research Center, Qom University of Medical Sciences, Qom, Iran.
2- Department of Social Medicine, Fucalty of Medicine, Qom University of Medical Sciences, Qom, Iran.
3- Gastroenterology & Hepatology Disease Research Center, Qom University of Medical Sciences, Qom, Iran. ,hormatia@yahoo.com
2- Department of Social Medicine, Fucalty of Medicine, Qom University of Medical Sciences, Qom, Iran.
3- Gastroenterology & Hepatology Disease Research Center, Qom University of Medical Sciences, Qom, Iran. ,
Abstract: (6645 Views)
Background and Objectives: Chronic viral hepatitis B is a global health problem, which, if not treated, can lead to some serious complications, such as liver cirrhosis and hepatocellular carcinoma. In this study, the effect of antiviral therapy with tenofovir, was investigated on reduction of liver fibrosis and improvement of liver function in patients with chronic hepatitis C.
Methods: In this clinical trial, 40 patients with chronic hepatitis B underwent antiviral therapy with tenofovir 300 mg daily. Demographic information and results of laboratory tests (before treatment and 6 months after the start of treatment), were collected using a checklist. Liver stiffness was measured and recorded using a fibroscan device (before and 6 months after the treatment). Data were analyzed using Wilcoxon and paired t- tests. The level of significance was considered to be p<0.05.
Results: Among 40 patients, one person was excluded from the project due to lack of follow-up. Of remaining 39 patients, 27 subjects (69.2%) were male and 12 subjects (30.8%) were female. The mean age of the patients was 47.53±13.68 years. The mean levels of AST, ALT, Child score, and liver stiffness did not show significant improvement during a 6-month follow-up according to Wilcoxon and paired t- tests.
Conclusion: This study showed that although hepatic fibrosis and liver function in patients with chronic hepatitis B are reversible after treatment, changes require long-term treatment and follow-up.
Methods: In this clinical trial, 40 patients with chronic hepatitis B underwent antiviral therapy with tenofovir 300 mg daily. Demographic information and results of laboratory tests (before treatment and 6 months after the start of treatment), were collected using a checklist. Liver stiffness was measured and recorded using a fibroscan device (before and 6 months after the treatment). Data were analyzed using Wilcoxon and paired t- tests. The level of significance was considered to be p<0.05.
Results: Among 40 patients, one person was excluded from the project due to lack of follow-up. Of remaining 39 patients, 27 subjects (69.2%) were male and 12 subjects (30.8%) were female. The mean age of the patients was 47.53±13.68 years. The mean levels of AST, ALT, Child score, and liver stiffness did not show significant improvement during a 6-month follow-up according to Wilcoxon and paired t- tests.
Conclusion: This study showed that although hepatic fibrosis and liver function in patients with chronic hepatitis B are reversible after treatment, changes require long-term treatment and follow-up.
Type of Study: Original Article |
Subject:
گوارش
Received: 2018/02/4 | Accepted: 2018/04/17 | Published: 2018/06/15
Received: 2018/02/4 | Accepted: 2018/04/17 | Published: 2018/06/15
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Owned by Qom University of Medical Sciences
Published by Qom University of Medical Sciences Press
eISSN: 2008-1375
pISSN: 1735-7799
Email: journal[at]muq.ac.ir
j.mua.ac[at]gmail.com
